small cap stocks « AGORACOM Small-cap Investor Relations Blog

Posts Tagged ‘small cap stocks’

Universal PropTech $UPI.ca Announces Agreements to Install Delta-X Trust Units at Retirement Home and Sports and School Facility $SNE $MSFT $HON

Posted by AGORACOM-JC at 8:54 AM on Tuesday, December 22nd, 2020

Announced agreements to install Delta-X Trust units in a Vaughan retirement home, and a sports and school complex.
As previously announced in a November 23, 2020 press release, UPI entered into an agreement with the Delta-X Group to test the Delta-X Trust proprietary face and temperature recognition software technology, with clients across Canada.
COVID-19 has infected more than 485,000 people in Canada with over 13,800 deaths. While the Canadian Government expects to vaccinate the majority of Canadians by the end of 2021, it is still unclear as to the length of time that vaccines will protect Canadians.
Technology such as Delta-X Trust can be a key tool to manage the flow of people in and out of high traffic public and private facilities, providing property managers with the protocols to improve the safety of the tenants and visitors to a site.

Toronto, Ontario–(December 22, 2020) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or “the Company”) is pleased to announce agreements to install Delta-X Trust units in a Vaughan retirement home, and a sports and school complex.

As previously announced in a November 23, 2020 press release, UPI entered into an agreement with the Delta-X Group to test the Delta-X Trust proprietary face and temperature recognition software technology, with clients across Canada. To this end, UPI has entered into agreements with UniversalCare Canada Inc. to install Delta-X unit within its Richview Retirement Residence facility, and with Mentana Group Inc. to install unit within their Vaughan Sports Village facility.

“The Company is pleased to be able to deploy the Delta-X Trust units at the Richview Retirement Residence, a premier Independent and Assisted Living home, and Sports Village, a multi-rink and school complex,” stated UPI CEO Chris Hazelton. “The Company and each of these facilities will scope out the unit protocols over the coming weeks to ensure the units provide additional security and protection for users of the facilities, and the Company expects installation to be completed in coming weeks. Seniors homes, schools and other institutional facilities are among the highest risk facilities to prevent the spread of COVID-19, and we are pleased that we can be part of the solution.”

COVID-19 has infected more than 485,000 people in Canada with over 13,800 deaths. While the Canadian Government expects to vaccinate the majority of Canadians by the end of 2021, it is still unclear as to the length of time that vaccines will protect Canadians. Technology such as Delta-X Trust can be a key tool to manage the flow of people in and out of high traffic public and private facilities, providing property managers with the protocols to improve the safety of the tenants and visitors to a site. These pilots are expected to provide the Company with better visibility regarding the interaction between key stakeholders, integration within building systems, and will inform wider go-to-market strategies. Other clients of the Company have expressed an interest to have Delta-X Trust units installed, and the Company will continue to refine the strategy to scale the opportunities.

New Technology – DELTA-X Trust

Delta-X™ Trust is a technology package that offers building administrators touchless facial recognition, temperature detection and multi-factor authentication (MFA) technology to improve hygiene and security standards in any public, high-risk or restricted-access environment. Delta-X™ Trust solutions can be applied to communities, office buildings, bus stations, airports, hotels, schools, hospitals, sports facilities and other public places with heavy traffic, helping to achieve intelligent security management and disease prevention.

About Universal PropTech Inc.

Universal PropTech Inc. (TSXV: UPI) is a leading building innovation company, selecting, integrating, deploying and maintaining PropTech in healthy buildings. As trusted advisors, we provide holistic evidence-driven solutions and services for building developers, owners and operators in Canada.

UPI operates through its wholly-owned subsidiary, VCI Controls Inc. (“VCI”), a leading supplier and integrator of PropTech healthy building solutions and services. VCI is an industry leader in the acquisition and deployment of intelligent building technology, including the integration of all building systems utilizing the latest in communications technologies and standards. VCI’s business focuses on digital controls and mechanical services, performance monitoring, and energy efficiency solutions.

With headquarters in Toronto, Universal PropTech has offices across Canada including, Halifax, Montreal, and Ottawa. For more information, visit www.universalproptech.com

Certain statements in this press release are forward-looking statements. The reader is cautioned that assumptions used in the preparation of such information, although considered reasonable by the Company at the time of preparation, may prove to be incorrect. Forward-looking statements, specifically those concerning future performance and other statements that are not historical fact, are subject to certain risks and uncertainties, and actual results may differ materially from the Company’s plans and expectations. These plans, expectations, risks and uncertainties are detailed herein and from time to time in the filings made by the Company with the TSX Venture Exchange (the “Exchange”) and securities regulators. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Trading in the securities of the Company should be considered highly speculative. All forward-looking information contained in this news release is expressly qualified in its entirety by this cautionary statement.

Neither the Exchange, nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

CONTACT INFORMATION

Universal PropTech Inc.

Chris Hazelton

Chief Executive Officer

(647) 300-2957

Tags: AI, Big data, Cloud Computing, Delta-X Global Corp., investing, IOT, PropTech, small cap stocks, stocks, tsx
Posted in Universal PropTech Inc. | Comments Off on Universal PropTech $UPI.ca Announces Agreements to Install Delta-X Trust Units at Retirement Home and Sports and School Facility $SNE $MSFT $HON

VIDEO – POET Technologies $PTK.ca $POETF Hits 52 Week High As “Flip-Chip” Enables The World’s Lowest-Cost and Smallest Optical Engine Of Its Kind

Posted by AGORACOM-JC at 7:32 AM on Tuesday, December 22nd, 2020

Understanding the world of Photonics isn’t the easiest thing small cap investors have had to understand. In fact, it may be the very hardest thing they’ve ever had to understand. However, given the fact we are the very reason current photonics devices aren’t living up to snuff trying to keep up with our surfing, streaming, binging and zooming – you start to see why understanding photonics and POET Technologies could open up investors to a whole new world.

We went beyond the press release with POET management to discuss the “Industry’s First Flip-Chip DML Lasers” No, we didn’t understand the title at first either ….. but the management trio on the Zoom did a great job explaining it in terms that are both compelling yet understandable.

Before watching this video, here is some important background information.

Photonics are critical to the next phase of semiconductor development. Semiconductors are an essential component of every electronic device on the planet.

Photonic devices create, detect and manipulate light. Laser generated light is fundamental to sensing, computing, data and telecommunications, which require the fastest transfer of data possible.

In short, all the surfing, streaming, binging and zooming we do requires 2 things to happen:

1. Massive data centres filled with tens of thousands of servers.

2. Speed … and we mean lighting speed that requires lasers to transfer all that data fast enough for you not to complain about 2 second latency when searching for last minute Christmas gift ideas (We see you)

Examples of the the biggest trends sucking up all that power and speed in computing today:

Cloud Computing
Artificial Intelligence
5G and Edge

HERE IS THE PROBLEM

Making photonics devices that are reliable is expensive in terms of both capital and labour.

Cost declines have not kept up with Moore’s Law, with most photonics devices built one at a time – and multiple different components must be able to interconnect seamlessly without constant testing.

The Result? Integration of components at wafer-scale has not been fully implemented even by the largest companies working for the past 20 years ….. UNTIL NOW

POET has developed a unique, disruptive and differentiating new entry into photonics markets.

The POET Optical Interposer™ Platform – patented photonics integration platform that enables lower cost and higher performance across a wide range of applications.

The press release announcing the industry’s first flip-chip DML lasers might very well take POET to a whole new level.

Watch this great first interview of many with:

Suresh Venkatesan, Chairman and CEO

Vivek Rajgarhia, President & General Manager

Thomas Mika, Executive Vice President and Chief Financial Officer

Tags: AI, Cloud Computing, lightbar, photonics, small cap, small cap stocks, stocks
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, POET Technologies | Comments Off on VIDEO – POET Technologies $PTK.ca $POETF Hits 52 Week High As “Flip-Chip” Enables The World’s Lowest-Cost and Smallest Optical Engine Of Its Kind

VIDEO – ThreeD Capital $IDK.ca $IDKFF Hits Another 52 Week High And 610% YTD As Investors Discover Sheldon Inwentash and IDK Are The Common Denominator On Many Big Small Cap Winners $PKK.ca $PKKFF $MTRX.ca $RACMF $HPQ.ca

Posted by AGORACOM-JC at 7:06 PM on Monday, December 21st, 2020

ThreeD Capital (IDK:CSE / IDKFF:OTCQB) prides itself on discovering great companies before everyone else … and so do shareholders who are being rewarded with another 52 week high thanks to Chairman and CEO Sheldon Inwentash, who is showing once again that he can find and invest in great “Ignored and undervalued companies” on his way to a 610% gain for IDK Year To Date.

He may make it look easy but Inwentash tirelessly casts a wide net 24/7/365 (trust us, we know) in his favourite industries to find best of breed companies in either Disruptive Technologies or Junior Resources. And when he finds them, he isn’t afraid to have IDK invest big and be patient, something most investors just aren’t willing to do when they’re fixated on just daily or even hourly moves.

That’s why IDK, is like and ETF for ground floor investments that small cap investors would either be unable to find (private) or unable to participate in (early round accredited investors) or unable to hold.

For new investors to the markets in 2021 who don’t know him but better get to know him ASAP, Sheldon Inwentash is one of the greatest investors in Canadian history. As Founder, Chairman and CEO of IDK, Inwentash’s track record of success speaks for itself, including successful exits in the hundreds of millions and even billions of dollars in previous years. His last investment company commanded a market cap north of $1 Billion and now he’s looking to create another success with IDK.

Will he do it? He’s sure off to a good start so far by quietly making investments over the past couple of years that are now starting to pay off. In this interview Inwentash discusses:

His investment philosophy
Some of his big 2020 winners including
- Peak Fintech $PKK – $PKKFF
- Loop Insights $MTRX – $RACMF
- HPQ Silicon $HPQ
- Esports Entertainment Group $GMBL
- Bluesky Digital $BTC
- ImagineAR $IP $IPNFF – where he is re-accumulating again
Why he’s investing heavily in gold juniors
Why he’s investing heavily in crypto currencies
Best of all, after one hell of a ride for the financial markets in 2020, Inwentash talks about why 2021 “is the year to be all in”

Watch this great interview … because when a legendary financier speaks, every small cap investor should be listening. We know we do.

Tags: artificial intelligence, blockchain, CSE, Digital, Disruptive companies, disruptive technologies, esports, gold, IOT, shrooms, small cap, small cap stocks
Posted in AGORACOM Via Satellite, ThreeD, ThreeD Capital | Comments Off on VIDEO – ThreeD Capital $IDK.ca $IDKFF Hits Another 52 Week High And 610% YTD As Investors Discover Sheldon Inwentash and IDK Are The Common Denominator On Many Big Small Cap Winners $PKK.ca $PKKFF $MTRX.ca $RACMF $HPQ.ca

Harborside Inc.$HBOR.ca Completes Acquisition of San Francisco Dispensary $HBOR.ca $VFF.to $HARV.ca $ACB.to

Posted by AGORACOM at 8:48 AM on Monday, December 21st, 2020

Expands Footprint with Social Equity Dispensary in Historic Haight-Ashbury District

Harborside Inc. (“Harborside”, or the “Company”) (CSE: HBOR), (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, announces the closing of the transactions contemplated by the previously announced agreement to acquire 50.1% of the equity (the “Shares”) of FGW Haight, Inc. (“FGW”), a California corporation which has the conditional use approval necessary to operate a cannabis dispensary and related businesses in the Haight Ashbury area of San Francisco, California (the “Acquisition”).

With the completion of the Acquisition, Harborside expands its retail dispensary footprint in the state of California to five and solidifies a strong presence in the historic and culturally-significant Haight-Ashbury district of San Francisco. The Company expects to complete the build-out, receive all necessary regulatory approvals, and open the social equity retail dispensary in the third quarter of 2021.

“I’m excited to continue to expand our footprint in California and look forward to serving consumers in Haight Ashbury,” said Peter Bilodeau, Interim CEO of Harborside. “Together, we will work with the team from FGW to give back to the community and support initiatives to address the negative impact of past cannabis policies which have disproportionally impacted low income and minority community members. This new location will also introduce the best-in-class service and unbeatable product selection that Harborside has become famous for to an iconic area of San Francisco.”

Upon closing of the Acquisition, Harborside paid an aggregate purchase price of USD $2,179,350 based on a post-build-out and proforma working capital enterprise value of USD $4,350,000 (the “Purchase Price”). The Purchase Price is comprised of: (a) USD $1,265,000 as consideration for convertible notes of FGW entitling the Company to such number of underlying Shares equal to 29.1% of the Shares; and (b) the balance of the Purchase Price in multiple voting shares (“MVS”) valued at CAD$125 per MVS as consideration to certain selling shareholders of FGW for 21% of the issued and outstanding Shares.

Subject to regulatory approval, Harborside has also agreed to purchase an additional 29.9% of the issued and outstanding Shares (the “Subsequent Shares”) to get to an 80% ownership of FGW, subject to regulatory approvals. The aggregate purchase price for the Subsequent Shares will be USD $1,300,650, which will be satisfied in MVS valued at the greater of: (i) the 30 day VWAP of the subordinate voting shares of the Company on the Canadian Securities Exchange (“CSE”) at the time of issuance less a discount multiplied by 100; (ii) CAD$150 per MVS; or (iii) such other price as may be approved by the CSE. Harborside also retains the right of first refusal to purchase, in its discretion, in whole or in part and in one or more closings, the remaining 20% of the Shares, subject to regulatory approvals.

About Harborside:
Harborside Inc. is one of the oldest and most respected cannabis retailers in California, operating three of the major dispensaries in the San Francisco Bay Area, a dispensary in the Palm Springs area outfitted with Southern California’s only cannabis drive-thru window, a dispensary in Oregon and a cultivation/production facility in Salinas, California. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the CSE trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at www.sedar.com.

Tags: American CBD, california cannabis, Cannabis, Canopy Growth Corp, CSE, Greenhouse, Haight-Ashbury, Hemp, Record, Revenue, small cap stocks
Posted in All Recent Posts, Harborside | Comments Off on Harborside Inc.$HBOR.ca Completes Acquisition of San Francisco Dispensary $HBOR.ca $VFF.to $HARV.ca $ACB.to

Dr. Trevor Champagne Appointed Chair of MedX Health Corp.’s $MDX.ca Medical Advisory Board $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-JC at 8:13 AM on Monday, December 21st, 2020

Nationally renowned dermatologist will lead advanced product development & innovation

Announced the appointment of Dr. Trevor Champagne as Chair of the Company’s Medical Advisory Board.
A member of the Advisory Board since 2018—among other distinguished members and world-class dermatologists Dr. Daniel Siegel, Dr. Per Hall, Dr. Joe Walls, and Dr. Dennis Reich—Dr. Champagne has helped position MedX as a leader in teledermatology.

MedX Health Corporation (“MedX” or the “Company”) (TSX-V: MDX), is pleased to announce the appointment of Dr. Trevor Champagne as Chair of the Company’s Medical Advisory Board. A member of the Advisory Board since 2018—among other distinguished members and world-class dermatologists Dr. Daniel Siegel, Dr. Per Hall, Dr. Joe Walls, and Dr. Dennis Reich—Dr. Champagne has helped position MedX as a leader in teledermatology.

Teledermatology is a subspecialty of dermatology that offers safe and effective virtual care—patient assessment and diagnosis—at a distance, eliminating the need for in-person appointments. With the world navigating through ongoing COVID-19 recovery measures, teledermatology’s advancement has never been more critical to patient care and outcomes. Dr. Champagne will drive ongoing innovation with MedX’s teledermatology offering, including the Company’s leading-edge image capture technology (SIAscopy®) for moles, lesions and other skin conditions via its secure, cloud-based patient management system (DermSecure®), which transmits and stores patient data through the assessment process. MedX’s SIAscopy® is the only technology that takes five images, including four spectrophotometric images 2 mm below the skin’s surface.

In addition to his leadership appointment at MedX, Dr. Champagne is a dermatologist at the Women’s College Hospital in Toronto, as well as an Assistant Professor (Clinician in Quality and Innovation, Division of Dermatology) at the University of Toronto’s Temerty Faculty of Medicine, Canada’s top-ranked medical school.

“In dermatology, it’s critical to have the diagnostic equipment required to provide quick, reliable results for patients in a pain-free way – and MedX delivers this like no other, thanks to their rigorous standards for safety and quality,” said Dr. Champagne. “MedX is a leader in teledermatology because they listen to the dermatology community to develop effective, forward-thinking tools and software that we as specialists, and our patients, need most. I’m honoured to be appointed Chair of the Advisory Board and look forward to working together with this well-respected team to take teledermatology to the next level.”

With both a Doctor of Medicine degree from Western University and a Master of Science, Health Systems Research from the University of Toronto, Dr. Champagne’s expertise spans dermatology and computer science. He has been particularly instrumental in the development of DermSecure®, MedX’s Patient Management Software, ensuring that it interacts efficiently and effectively with a dermatologist’s workflow. He is also overseeing exciting new developments in Artificial Intelligence (AI) functionality, an area of rapid growth, which he will continue to guide in the years to come.

“We’re very proud to have a leader of Dr. Champagne’s calibre as the first Chair of our Scientific and Medical Advisory Board,” said Mike Druhan, President, Dermatology Services and Products. “His continued leadership and foresight will ensure we are in lockstep with the needs of the dermatology community, not only improving patient care and outcomes today but anticipating and meeting future needs. We are all driven to save lives.”

About MedX
MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also embedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain-free, non-invasive manner, with its software than creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA, and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union, Brazil and Turkey. Visit https://medxhealth.com .

Investor Relations Contact:
Bill Mitoulas
Email: [email protected]
Tel: +1.416.479.9547

Tags: DermSecure, MedX, MoleMate, Simsys, Skin Cancer, small cap stocks, stocks
Posted in MedX Health Corporation | Comments Off on Dr. Trevor Champagne Appointed Chair of MedX Health Corp.’s $MDX.ca Medical Advisory Board $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca

Cardiologists to Use the HeartCheck(TM) #CardiBeat With #ECG Triaging Services for Remote Patient ECG Monitoring – CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 7:25 AM on Monday, December 21st, 2020

Patient Self-Monitoring Extends Physicians’ Reach for Monitoring During COVID-19

Confirms the start of an out-of-office ECG monitoring program using the HeartCheck™ CardiBeat Handheld ECG monitor, the GEMS™ Mobile RPM Smartphone app and the SMART Monitoring ECG triaging service to support prescribed in-home arrhythmia monitoring.
Heart Health Institute, a large arrhythmia practice network located in the Greater Toronto Area, will be recommending the HeartCheck™ CardiBeat to their cardiac patients for up to six months of in-home, arrhythmia self-monitoring use with an emphasis on detecting a recurrence of atrial fibrillation and supraventricular tachycardia.

TORONTO, ON / December 20, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) (“CardioComm” or the “Company“), a global provider of consumer heart monitoring and electrocardiogram (“ECG“) device and software solutions, confirms the start of an out-of-office ECG monitoring program using the HeartCheck™ CardiBeat Handheld ECG monitor, the GEMS™ Mobile RPM Smartphone app and the SMART Monitoring ECG triaging service to support prescribed in-home arrhythmia monitoring.

The Heart Health Institute (“HHI“), a large arrhythmia practice network located in the Greater Toronto Area (Ontario, Canada), will be recommending the HeartCheck™ CardiBeat to their cardiac patients for up to six months of in-home, arrhythmia self-monitoring use with an emphasis on detecting a recurrence of atrial fibrillation and supraventricular tachycardia.

CardioComm’s GEMS™ Mobile Smartphone app supports physician and research-based remote patient monitoring (“RPM“) requirements including providing rapid ECG reporting directly to the prescribing physician’s electronic medical records as patient triggered ECGs are taken. ECGs recorded by HHI patients using the GEMS™ Mobile RPM Smartphone app and the HeartCheck™ CardiBeat be rapidly triaged by CardioComm’s SMART Monitoring ECG service to detect for the presence of any number of arrhythmias. Any submitted ECG recordings that show a presence of a cardiac arrhythmia will be flagged so that HHI patients may be contacted and a follow-up visit scheduled. ECG reports generated through GEMS™ Mobile are eligible for medical service reimbursement in both Canada and the US.

Physicians at HHI intend to introduce the use of the HeartCheck™ ECG/arrhythmia monitoring technology to patients with difficult to capture arrhythmias and to reduce clinical workload in dealing with COVID-19 precautions. Due to COVID-19, patients are reluctant to visit their physician for cardiac testing and some pratices have also implemented new protocols that have made it more challenging to see their patients.

Under the GEMS™ Mobile RPM model, patients will be able to purchase the HeartCheck™ CardiBeat directly through the HHI offices or on-line directly from CardioComm with an HHI physician referral. ECG reporting will be made available at no cost to the patients over a six month monitoring period or until a diagnosis has been made. Following completion of the HHI monitoring period, patients will be able to continue to use the wireless HeartCheck™ CardiBeat ECG device and GEMS™ Mobile app under the Company’s consumer use model.

The GEMS™ Mobile RPM app is available in Android and Apple Smartphone compatible versions as a free downloadable app and allows users to generate ECG reports to show to their physician. The app also allows users to request their ECG to be reviewed by CardioComm’s SMART Monitoring ECG reading service where the user does not have direct connectivity to their treating physician.

To learn more about CardioComm’s products and for further updates regarding HeartCheck™ ECG device RPM use by healthcare professionals please visit the Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com.

About CardioComm Solutions

CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485:2016 MDSAP certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).

FOR FURTHER INFORMATION PLEASE CONTACT:

Etienne Grima, Chief Executive Officer
1-877-977-9425 x227
[email protected]
[email protected]

Forward-looking statements

This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: CardioComm Solutions, Inc

Tags: CardioComm SMART Monitoring ECG reading, CSE, ECG, GEMS™ ECG, investments, mhealth, small cap stocks
Posted in CardioComm Solutions | Comments Off on Cardiologists to Use the HeartCheck(TM) #CardiBeat With #ECG Triaging Services for Remote Patient ECG Monitoring – CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

VIDEO – ImagineAR $IP.ca $IPNFF Racks Up Big Name Wins In 2020. With Big Cash On Hand, CEO Expects Another Big Year In 2021 $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

Posted by AGORACOM-JC at 8:00 PM on Sunday, December 20th, 2020

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

As the name implies, ImagineAR (IP:CSE / IPNFF:OTCQB) is an Augmented Reality Company … but they’re not just any AR company. Imagine enables businesses to create their own mobile phone AR campaigns with no programming or technology experience. Why is that important? Ask Apple CEO Tim Cook who stated

“AR Will play an important role in how we use technology in the future – and promises to be as influential in our society as the smart phone”

For those of you that are just discovering Augmented Reality, “AR” is essentially a technology that lays digital images and graphics over the real world, typically by looking through your cell phone or special glasses. If you think it sounds like a gimmick, it isn’t. AR will create an entire new revenue stream for businesses, organizations and sports teams that will boggle the mind in the next 3 years.

ImagineAR provides small cap investors with an opportunity to participate in the growth of this mega market in the making …. and they they signed the MASSIVE brand contracts in 2020 to prove it:

DECEMBER 10 – ImagineAR Announces Agreement with Indian Superstar Singer Ananya Birla

NOVEMBER 25 – ImagineAR Signs Two Year Partnership Agreement with Real Sociedad of La Liga To Provide Interactive Augmented Reality Experiences for Fans

NOVEMBER 20 – ImagineAR to Deliver Immersive AR Conference Experience for Shoppers Drug Mart

“Shoppers Drug Mart is thrilled to be the global pioneer in integrating mobile augmented reality with virtual events.” (Karen Bossion, Director Conferences & Events)

SEPTEMBER 30 – ImagineAR Signs Two-Year Agreement with Valencia C.F. Of La Liga To Provide Interactive Augmented Reality Experiences for Almost 7 Million Fans Around The World

SEPTEMBER 24 – NFL Alumni Academy and ImagineAR Sign 5 Year Partnership Agreement

We could go on but you get the pont …. and some of the smartest people in sports agree the Company is a best of breed company:

“In my 30 years working in sports and entertainment technology, I have never seen a solution that provides such a high level of interaction & engagement” (Chris Dill)

“The ImagineAR platform is years ahead of every other company today” (WaV Sports)”

“ImagineAR has one of the most amazing mobile technologies I have seen to date” (Gus Frerotte)

“The ImagineAR augmented reality platform is truly a gamechanger for sports organizations and athletes to deliver in-home mobile phone engagement” (WaV Sports)

2020 was a great year and a major turning point for ImagineAR and sets up the Company for an ever far better 2021 … which explains why our latest interview with CEO Alen Paul Silverrstieen is by far the best one of the year.

Tags: Apple, AR, augmented reality, Camerai, CSE, D-BOX Technologies Inc., investment, small cap, small cap stocks, stocks, Tipit, tsx, tsx-v
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, Imagine AR | Comments Off on VIDEO – ImagineAR $IP.ca $IPNFF Racks Up Big Name Wins In 2020. With Big Cash On Hand, CEO Expects Another Big Year In 2021 $DBO.ca $YDX.ca $SEV.ca $NTAR.ca

EVENT: New Age Metals $NAM.ca $NMTLF Virtual Roadshow Today at 12:00 pm EST $LIX.ca $LI.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 10:37 AM on Friday, December 18th, 2020

Tags: CSE, lithium, palladium, PGM, PGM Demand, Pine Zone, rhodium, small cap stocks, stocks, tsx
Posted in New Age Metals | Comments Off on EVENT: New Age Metals $NAM.ca $NMTLF Virtual Roadshow Today at 12:00 pm EST $LIX.ca $LI.ca $WM.ca $PDL.ca $GLEN

Universal PropTech $UPI.ca Announces the Appointment of Robert Daniels to the Advisory Board $SNE $MSFT $HON

Posted by AGORACOM-JC at 8:38 AM on Friday, December 18th, 2020

Announced the appointment of Mr. Robert Daniels to the Advisory Board
Mr. Daniels is a long-time creator and developer of new business ventures and initiatives in the real estate and sustainability fields.
With a career spanning over 30 years, Mr. Daniels has been involved in substantial multi-million-dollar ventures in real estate and land development, commercial property investment and renewable power totalling over $1.4 B.
As an industry leader, he became one of the first large-scale builders of super energy efficient homes in Canada and one of the first independent full-scale retailers of environmentally responsible products.

Toronto, Ontario–(December 18, 2020) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or “the Company”) is pleased to announce the appointment of Mr. Robert Daniels to the Advisory Board.

Mr. Daniels is a long-time creator and developer of new business ventures and initiatives in the real estate and sustainability fields. With a career spanning over 30 years, Mr. Daniels has been involved in substantial multi-million-dollar ventures in real estate and land development, commercial property investment and renewable power totalling over $1.4 B. As an industry leader, he became one of the first large-scale builders of super energy efficient homes in Canada and one of the first independent full-scale retailers of environmentally responsible products.

Mr. Daniels is a former board member of the Greater Toronto Home Builders Association, the Urban Development institute and numerous private companies and charitable organizations in Ontario. He is a graduate of The Wharton School of Business at the University of Pennsylvania. As a Climate Reality Leader, he holds a certification in ISO-14064-3: GHG Validation and Verification from the University of Toronto.

Mr. Daniels will support the Company’s efforts in investments and acquisitions of PropTech companies together with overall business development knowledge of commercial, institutional and multi-residential asset owners and managers.

“I have been a serial entrepreneur my entire life. I understand the leadership required to not only make deals, but to make them successful, and I have joined as an Advisor because I believe that this type of participation can do just that to help with Universal PropTech’s strategy,” commented Robert Daniels, Advisor, Universal PropTech Inc.

“We are excited to have Bob support us in our growth campaign to acquire, invest and license PropTech,” stated Chris Hazelton, Chief Executive Officer of Universal PropTech Inc. “His development and investment experiences will be of tremendous value going forward.”

About Universal PropTech Inc.

UPI operates through its wholly owned subsidiary, VCI Controls Inc. (“VCI”), a leading supplier and integrator of PropTech healthy building solutions and services. VCI is an industry leader in the acquisition and deployment of intelligent building technology, including the integration of all building systems utilizing the latest in communications technologies and standards. VCI’s business focuses on digital controls and mechanical services, performance monitoring, and energy efficiency solutions.

With headquarters in Toronto, Universal PropTech has offices across Canada including, Halifax, Montreal, and Ottawa. For more information, visit www.universalproptech.com.

CONTACT INFORMATION

Universal PropTech Inc.
Chris Hazelton
Chief Executive Officer
(647) 300-2957

Tags: AI, Big data, Cloud Computing, Delta-X Global Corp., investing, IOT, PropTech, small cap stocks, stocks, tsx, tsx-v
Posted in Universal PropTech Inc. | Comments Off on Universal PropTech $UPI.ca Announces the Appointment of Robert Daniels to the Advisory Board $SNE $MSFT $HON

Empower Clinics $CBDT.ca $EPWCF Signs Definitive Agreement to Acquire Momentum Health With 7 Canadian Clinics. Begins Planning for Nationwide Rollout $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 4:16 PM on Thursday, December 17th, 2020

Acquisition Will Expand Company’s North American Footprint And Strengthen Vertical Integration From Patients To Laboratory, Strengthening Testing and Bubble Initiatives

Announced the execution of a definitive share purchase agreement dated December 16, 2020 to acquire Lawrence Park Health and Wellness Clinic Inc., 1100900 Canada Inc. dba Atkinson, and Momentum Health Inc.
Momentum Health operates a network of medical clinics with a team of healthcare professionals who provide para-medical care by applying a holistic and hands-on approach working with patients to unlock potential well-being.
Key services include physiotherapy, chiropractic, massage therapy, traditional Chinese medicine, athletic therapy and others.
Acquisition will include two standalone wellness clinics and five new co-located clinics in the Greater Toronto Area of Ontario, Canada, with immediate access to in excess of 20,000 patients.

VANCOUVER, BC / December 17, 2020 / Empower Clinics (CSE:CBDT)(OTC PINK:EPWCF)(FRA:8EC) (the “Company” or “Empower”), an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and developing novel COVID-19 testing protocols for CE, FDA and Health Canada approval, is pleased to announce the execution of a definitive share purchase agreement dated December 16, 2020 (the “Agreement“) to acquire Lawrence Park Health and Wellness Clinic Inc., 1100900 Canada Inc. dba Atkinson, and Momentum Health Inc. (collectively “Momentum Health“).

Steven McAuley, Chairman and CEO of Empower stated “The acquisition of Momentum Health will be a significant milestone for both Empower and its shareholders that we expect will provide Empower with a growing accretive business, as well as, a winning business model with plans for immediate expansion across the Greater Toronto Area, the province of Ontario and then nationwide in very rapid succession. It is anticipated that this immediate and rapid nationwide expansion plan will be made possible by combining the winning Momentum Health model with the financial, marketing and operational control resources already successfully deployed by Empower in building its US operations, including the successful win of a $1.2 million testing contract with a film and television studio within just 45 days of acquiring our KAI Medical Lab. Significant discussions are already underway with potential nationwide partners and we expect to have developments in the very near future.”

ACQUISITION INCLUDES 7 CLINICS IN GREATER TORONTO AREA WITH IMMEDIATE PLANS TO EXPAND “CLINIC-IN-CLINIC” MODEL ACROSS CANADA.

Momentum Health operates a network of medical clinics with a team of healthcare professionals who provide para-medical care by applying a holistic and hands-on approach working with patients to unlock potential well-being. Key services include physiotherapy, chiropractic, massage therapy, traditional Chinese medicine, athletic therapy and others. The full range of services can be viewed at www.momentumhealthclinic.com.

The acquisition will include two standalone wellness clinics and five new co-located clinics in the Greater Toronto Area of Ontario, Canada, with immediate access to in excess of 20,000 patients.

More importantly, it is expected that expansion will be at a very attractive and cost-effective model of opening “clinics-within-clinics” in which the Company proposes to partner with large care facilities to provide para-medical clinics inside the physical location of the primary care facility. This model results in a win-win for both Empower and the primary care facility partner as follows:

Substantially improved care for patients of the primary care facility
Significantly reduced start-up costs for Empower
Immediate access to the large patient base of the primary care facility
Immediate rental income for the primary care facility

With this proven winning model, the nationwide roll-out it is planned to commence immediately upon closing of the acquisition with expansion in the Greater Toronto Area, followed by expansion throughout Ontario and finally West through all Provinces with a standardized brand and technology platform.

Moreover, the acquisition includes incentives for the two Co-Founders of Momentum Health to open an additional 30 clinics across Canada.

CEO McAuley added “Having Dr. Rabinowitz and Dr. Tsimerman join me in leadership to rapidly expand Empower’s clinic footprint across Canada will be invaluable toward meeting our ambitious objectives.”

Momentum Co-Founder Dr. Robinowitz commented “Joining Empower provides us with the opportunity to scale an intricately designed health care model alongside the outstanding professionals currently on their team. This transaction will not only allow our current patients to have increased access to integrative care, we also strive to exponentially increase our patient base with strategic, nationwide expansion.”

Momentum Co-Founder Dr. Tsimerman commented “I am thrilled to be joining Empower Clinics with a shared vision of nationwide, truly integrative medical care based on patient – centric services. This unique opportunity allows us to provide an unparalleled patient experience and create a leading approach to modernized health care.”

TERMS OF ACQUISITION

Pursuant to the terms of the Agreement, Empower will pay the vendors of Momentum Health $275,000 cash at closing (including $44,648 to settle an outstanding debt of Momentum Health) with an additional $75,000 to be withheld as a holdback for adjustments, for an aggregate cash payment of $350,000. In addition, at closing, Empower will issue Dr. Jordan Rabinowitz and Dr. Aviv Tsimerman or their affiliates 5,128,204 common shares in the capital of Empower (at a deemed price of $0.0975 per share), 2,564,102 of which will be subject to contractual resale restrictions resulting in them being released quarterly from the date of closing in eight (8) equal instalments.

PERFORMANCE INCENTIVES TO OPEN 30 ADDITIONAL LOCATIONS

The acquisition also includes long-term performance incentives for Dr. Rabinowitz and Dr. Tsimerman. If, within 18 months from the closing date, the Company or its affiliates have opened and have operating an aggregate of ten (10) new clinic locations in Canada (“Milestone One”), each of Dr. Rabinowitz and Dr. Tsimerman shall be entitled to receive incentive stock options of Empower to purchase 1,875,000 common shares of Empower, vesting as follows:

1/3 immediately;
1/3 upon of the Company or its affiliates having opened and operating an aggregate of twenty (20) new clinic locations in Canada; and
1/3 upon of the Company or its affiliates having opened and operating an aggregate of thirty (30) new clinic locations in Canada.

ADDITIONAL DETAILS

Empower has agreed to enter into employment agreements with Dr. Rabinowitz and Dr. Tsimerman on closing of the acquisition, to lead the Canadian clinic expansion strategy.

Completion of the acquisition contemplated by the Agreement is subject to customary closing conditions which the Company anticipates being completed on or before December 21, 2020.

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics

ABOUT EMPOWER:

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors:
Dustin Klein
Director
[email protected]
720-352-1398

Investors:
Steven McAuley
CEO
[email protected]
604-789-2146

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include, but are not limited to, statements regarding: the Company’s nationwide rollout and timing and results of such rollout; the Company expecting the acquisition will provide Empower with a growing accretive business, as well as, a winning business model with plans for immediate expansion across the Greater Toronto Area, the province of Ontario and then nationwide in very rapid succession; the Company’s expectation for the costs of expansion; and the Company’s plans to partner with large care facilities to provide para-medical clinics inside the physical location of the primary care facility and the results of such model. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Kai Medical Laboratory acquisition may not be completed on the terms expected or at all; that the Company’s products may not work as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse affect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed transaction; and other factors beyond the Company’s control; as well as those risk factors discussed or referred to in the Company’s disclosure documents filed with the securities regulatory authorities in certain provinces of Canada and available at www.sedar.com. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

Tags: covid19, Covid19 testing, CSE, Diagnos Inc, investments, Kai Medical Laboratory, small cap stocks, tsx, tsx-v
Posted in All Recent Posts, Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca $EPWCF Signs Definitive Agreement to Acquire Momentum Health With 7 Canadian Clinics. Begins Planning for Nationwide Rollout $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posts Tagged ‘small cap stocks’

Categories